EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells

Giuseppina Bruno iD, Michele Pietrafesa, Fabiana Crispo, Annamaria Piscazzi, Francesca Maddalena, Guido Giordano, Vincenza Conteduca, Marianna Garofoli, Almudena Porras, Franca Esposito, Matteo Landriscina

Journal of Molecular Medicine · 2024-10 · 102 (10) · 1285-1296

DOI: 10.1007/s00109-024-02479-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Medicine, online erschienen am 29.08.2024. Verfasst von Giuseppina Bruno und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology and Biomolecular Therapy Unit, Department of Medical and Surgical Sciences, University of Foggia, Viale Pinto 1, 71122, Foggia, Ital…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Signal Transduction, Organelle Biogenesis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lega Italiana Lotta Tumori (LILT), Programma Operativo Nazionale (PON) Ricerca e Innovazione 2014-2020, Ministero dell'Istruzione, dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic rewiring promotes cancer cell adaptation to a hostile microenvironment, representing a hallmark of cancer. This process involves mitochondrial function and is mechanistically linked to the balance between mitochondrial biogenesis (MB) and mitophagy. The molecular chaperone TRAP1 is overexpressed in 60–70% of human colorectal cancers (CRC) and its over-expression correlates with poor clinical outcome, being associated with many cancer cell functions (i.e. adaptation to stress, protection from apoptosis and drug resistance, protein synthesis quality control, metabolic rewiring from glycolysis to mitochondrial respiration and vice versa). Here, the potential new role of TRAP1 in regulating mitochondrial dynamics was investigated in CRC cell lines and human CRCs. Our results revealed an inverse correlation between TRAP1 and mitochondrial-encoded respiratory chain proteins both at transcriptional and translational levels. Furthermore, TRAP1 silencing is associated with increased mitochondrial mass and mitochondrial DNA copy number (mtDNA-CN) as well as enhanced MB through PGC-1α/TFAM signalling pathway, promoting the formation of new functioning mitochondria and, likely, underlying the metabolic shift towards oxidative phosphorylation. These results suggest an involvement of TRAP1 in regulating MB process in human CRC cells. Key messages TRAP1 inversely correlates with protein-coding mitochondrial gene expression in CRC cells and tumours. TRAP1 silencing correlates with increased mitochondrial mass and mtDNA copy number in CRC cells. TRAP1 silencing favours mitochondrial biogenesis in CRC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSignal TransductionOrganelle BiogenesisHSP90 Heat-Shock ProteinsMitochondriaMitochondrial ProteinsTranscription FactorsDNA-Binding ProteinsHumansCell Line, TumorGene Expression Regulation, NeoplasticDNA, MitochondrialOxidative Phosphorylation

Stichwörter der Autor:innen

Colorectal cancerMetabolismMitochondrial biogenesisPeroxisome proliferation-activated receptor gamma coactivator α1-alphaTNF receptor-associated protein 1Transcription factor A mitochondrial

Substanzen

TRAP1 protein, humanPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humanHSP90 Heat-Shock ProteinsMitochondrial ProteinsTranscription FactorsDNA-Binding ProteinsTFAM protein, humanDNA, Mitochondrial

Autor:innen und Institutionen

  • Medical Oncology and Biomolecular Therapy Unit, Department of Medical and Surgical Sciences, University of Foggia, Viale Pinto 1, 71122, Foggia, Italy. giuseppina.bruno@unifg.it.
  • Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, 85028, Rionero in Vulture, Potenza, Italy.
  • Medical Oncology and Biomolecular Therapy Unit, Department of Medical and Surgical Sciences, University of Foggia, Viale Pinto 1, 71122, Foggia, Italy.
  • Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, 28040, Madrid, Spain.
  • Health Research Institute of the Hospital Clínico San Carlos (IdISSC), 28040, Madrid, Spain.
  • Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131, Naples, Italy.

ORCID-Profile: Giuseppina Bruno

Förderung

  • Lega Italiana Lotta Tumori (LILT)
  • Programma Operativo Nazionale (PON) Ricerca e Innovazione 2014-2020
  • Ministero dell'Istruzione, dell'Università e della Ricerca

Zitieren

APA

Bruno, G., Pietrafesa, M., Crispo, F., Piscazzi, A., Maddalena, F., Giordano, G., Conteduca, V., Garofoli, M., Porras, A., Esposito, F., & Landriscina, M. (2024). TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells. Journal of Molecular Medicine, 102(10), 1285-1296. https://doi.org/10.1007/s00109-024-02479-9

Vancouver

Bruno G, Pietrafesa M, Crispo F, Piscazzi A, Maddalena F, Giordano G, et al. TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells. Journal of Molecular Medicine. 2024;102(10):1285-1296. doi:10.1007/s00109-024-02479-9

BibTeX
@article{Bruno2024,
  author = {Bruno, Giuseppina and Pietrafesa, Michele and Crispo, Fabiana and Piscazzi, Annamaria and Maddalena, Francesca and Giordano, Guido and Conteduca, Vincenza and Garofoli, Marianna and Porras, Almudena and Esposito, Franca and Landriscina, Matteo},
  title = {TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells},
  journal = {Journal of Molecular Medicine},
  year = {2024},
  volume = {102},
  number = {10},
  pages = {1285--1296},
  doi = {10.1007/s00109-024-02479-9}
}
Kostenlos starten →